NL-OMON28085已完成3 期
Reducing fatigue in visually impaired adults with E-nergEYEze: An RCT to assess the cost-effectiveness of a blended vision-specific E-health based cognitive behavioral & self-management intervention’
Amsterdam University Medical Centres0 个研究点目标入组 172 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Visually impaired (according to WHO criteria and guidelines of the low vision rehabilitation centers) adult outpatients (18+) from Dutch low vision rehabilitation organisations (i.e. Royal Dutch Visio and Bartiméus) who experience severe fatigue (CIS-score>35), have internet-access at home and are able to speak the Dutch language adequately, will be eligible to participate.
排除标准
- •Exclusion criteria are: severe cognitive limitations assessed with the 6-item screener (short validated Mini Mental State Examination with a score <3), or currently receiving treatment or having received treatment in the last 12 months for another comorbid disease that clearly is the main cause of fatigue (i.e. multiple sclerosis (MS), cancer, psychiatric disorder).
研究者
相似试验
招募中
不适用
Reducing fatigue in visually impaired adults with E-nergEYEze: An RCT to assess the cost-effectiveness of a blended vision-specific E-health based cognitive behavioral & self-management intervention.Vermoeidheid(fatigue) sight lossheavinessovertirednessvisual disability (visually impaired)10047518NL-OMON52602Vrije Universiteit Medisch Centrum187
尚未招募
不适用
Verification of eye fatigue suppression effect by ingesting test foods. A placebo-controlled, Simple Randomization, open, cross over trial.healthy adultJPRN-UMIN000031400otte Co., Ltd.10
已完成
不适用
Verification of eye fatigue suppression effect by ingesting test foods. A placebo-controlled, Simple Randomization, double blind, cross over trial.healthy adultJPRN-UMIN000037406School of Allied Health Sciences, Kitasato University50
已完成
不适用
Objective determine visual fatigueJPRN-UMIN000021964Osaka university100
进行中（未招募）
不适用
Prevention of vision loss in patients with age-related neovascular macular degeneration by intravitreal injection of bevacizumab and ranibizumab in a typical outpatient setting - VIBERAEUCTR2007-004721-23-DEKlinikum Bremen-Mitte gGmbH